PROGNOSTIC IMPLICATIONS OF MORPHOLOGY AND KARYOTYPE IN PRIMARY MYELODYSPLASTIC SYNDROMES
Authors:
- RH JACOBSRJRH JACOBS
- MA CORNBLEETMCMA CORNBLEET
- JW VARDIMANJVJW VARDIMAN
- RA LARSONRLRA LARSON
- MM LEBEAUMLMM LEBEAU
- JD ROWLEYJRJD ROWLEY
- 1 June 1986
- journal article
- research article
- Vol. 67 (6) , 1765-1772
Abstract
Forty-nine patients with primary myelodysplastic syndromes (MDS) were subclassified according to French-American-British (FAB) Cooperative Group criteria. Eight patients had acquired idiopathic sideroblastic anemia (AISA), ten had chronic myelomonocytic leukemia (CMMoL), 14 had refractory anemia (RA), nine had refractory anemia with excesss blasts (RAEB), and five had refractory anemia with excess blasts in transformation (RAEB-T); three patients could not be subclassified. The actuarial median survival for patients with AISA or with RA had not been reached at 60 months of follow-up. The median survival times for patients with CMMoL, RAEB, and RAEB-T were 25, 21, and 16 months, respectively. The percentages of patients with each subtype who developed ANLL were none in AISA, 20% in CMMoL, 7% in RA, 56% in RAEB, and 40% in RAEB-T. Patients with CMMoL had a poor prognosis independent of transformation to acute nonlymphocytic leukemia (ANLL), whereas patients with RAEB and RAEB-T had a high incidence of transformation and short survival times. Clonal chromosomal abnormalities were present in bone marrow cells from 19 patients at the time of diagnosis, and two others developed an abnormal karyotype at the time of leukemic transformation. The most frequent abnormalities, including initial and evolutionary changes, were trisomy 8 (9 patients), deletion of 5q (4 patients), and deletion of 20q (4 patients). The median survival times were 32 months for patients with an abnormal karyotype, and 48 months for those with a normal karyotype (P = 0.2). Specific chromosomal abnormalities were not associated with particular histologic subtypes; however, a high percentage of patients with RAEB and RAEB-T had an abnormal clone (89% and 80%, respectively). The percentages of patients with clonal abnormalities were 13% for AISA, 20% for CMMoL, and 29% for RA. The MDS transformed to ANLL in 42% of patients with an abnormal karyotype, compared to 10% of those with an initially normal karyotype (P < .01). Among patients with RA, RAEB, and RAEB-T, the risk of leukemic transformation was confined to those with an abnormal karyotype (P < .01). Thus, in the present study, morphology and karyotype combined were the best indicators of outcome in patients with MDS.Keywords
This publication has 19 references indexed in Scilit:
- Management of Myelodysplastic SyndromesAnnals of Internal Medicine, 1985
- Cytogenetic findings in the dysmyelopoietic syndromeCancer, 1982
- NON-RANDOM CHROMOSOME-ABNORMALITIES IN ACUTE-LEUKEMIA AND DYSMYELOPOIETIC SYNDROMES IN PATIENTS WITH PREVIOUSLY TREATED MALIGNANT DISEASE1981
- Human PreleukemiaAnnals of Internal Medicine, 1980
- DYSMYELOPOIETIC SYNDROME - SEQUENTIAL CLINICAL AND CYTOGENETIC STUDIES1980
- CHRONIC MYELODYSPLASTIC SYNDROME (PRELEUKEMIA) WITH THE PHILADELPHIA-CHROMOSOME1980
- Chromosome studies in preleukemic states. IV. Myeloproliferative versus cytopenic disordersCancer, 1978
- DELETION OF LONG ARM OF CHROMOSOME-20 [DEL(20)(Q11)] IN MYELOID DISORDERS1978
- Proposals for the Classification of the Acute Leukaemias French‐American‐British (FAB) Co‐operative GroupBritish Journal of Haematology, 1976
- CHROMOSOMAL BANDING-PATTERNS IN ACUTE NONLYMPHOCYTIC LEUKEMIA1976